<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28765" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, Schwann Cells</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fallon</surname>
            <given-names>Matthew</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tadi</surname>
            <given-names>Prasanna</given-names>
          </name>
          <aff>Asram Medical College, Eluru, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Fallon declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasanna Tadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28765.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Schwann cells embryologically derive from the neural crest. They myelinate peripheral nerves and serve as the primary glial cells of the peripheral nervous system (PNS), insulating and providing nutrients to axons. Myelination increases conduction velocity along the axon, allowing for the saltatory conduction of impulses.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref>&#x000a0;Nonmyelinating Schwann cells do not wrap axons to improve conduction, but still, provide trophic support and cushioning to the unmyelinated axons.<xref ref-type="bibr" rid="article-28765.r2">[2]</xref></p>
      </sec>
      <sec id="article-28765.s2" sec-type="Structure">
        <title>Structure</title>
        <p>Each Schwann cell makes up a single myelin sheath on a peripheral axon, with each ensuing myelin sheath made by a different Schwann cell, such that numerous Schwann cells are needed to myelinate the length of an axon. This arrangement is in contrast to oligodendrocytes, the myelinating cell of the central nervous system (CNS), which form myelin sheaths for multiple surrounding axons. Schwann cells are surrounded by a basal lamina, while oligodendrocytes are not. Between adjacent myelin sheaths, there are gaps of approximately 1 micrometer, called nodes of Ranvier. There is a concentration of voltage-gated sodium channels at the node, which is the site of saltatory conduction.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref>&#x000a0;Schmidt-Lanterman incisures are cytoplasmic outpouchings that interrupt compact myelin in heavily myelinated neurons. They contain a high density of gap junctions and other cell junctions, serving a role in communication and maintenance of the Schwann cell.<xref ref-type="bibr" rid="article-28765.r3">[3]</xref></p>
      </sec>
      <sec id="article-28765.s3" sec-type="Function">
        <title>Function</title>
        <p>Schwann cells serve as the myelinating cell of the PNS and support cells of peripheral neurons. A Schwann cell forms a myelin sheath by wrapping its plasma membrane concentrically around the inner axon. While the nucleus remains fixed, the inner turn of the glial cell membrane spirals around the axon to add membrane layers, or lamellae, to the myelin sheath. The plasma membrane of Schwann cells has an extremely high lipid content, and cholesterol is particularly important for assembling the myelin sheath. The compact myelin sheath insulates the axon segment, significantly reducing membrane capacitance and increasing conduction velocity.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref> Neuregulin-type III expression on axons is essential for survival and maturation of Schwann cell precursors, and the degree of myelination depends on the amount of neuregulin on the surface of the axon.<xref ref-type="bibr" rid="article-28765.r4">[4]</xref><xref ref-type="bibr" rid="article-28765.r5">[5]</xref>&#x000a0;Schwann cells also provide energy metabolites to axons, shuttling them through monocarboxylate transports available along the surface of the axon and inner membrane of the Schwann cell.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref></p>
        <p>Schwann cells are critical in response to PNS axon damage and axon regeneration. Wallerian degeneration will occur distal to the injury site. The distal axon segment dies and Schwann cells, followed by macrophages, clear the dead cell contents, and promote axon regeneration. Schwann cells undergo several phenotypic changes at this time: they activate myelin breakdown, up-regulate the expression of cytokines (including TNF-a) to recruit macrophages to the injury site, up-regulate neurotrophic factors to stimulate axon regeneration and neuron survival, and organize a regeneration pathway along their basal lamina tube to guide axon growth. Axonotmesis and neurotmesis are the main types of PNS nerve injury. In axonotmesis, such as in a crush injury, the axon suffers disruption, but the basal lamina tube of the Schwann cells remain. The lumen of the tube provides guidance cues to the regenerating axon sprout as it grows, promoting highly effective axon regeneration and restoration of function in 3 to 4 weeks. In neurotmesis, such as in a cut&#x000a0;injury, the axon, Schwann cell basal lamina, and surrounding connective tissue sheath are disrupted. The regenerating axon and its associated Schwann cells still grow from the proximal to the distal nerve stump. Because of targeting errors in the absence of the basal lamina tube, correct reinnervation and recovery of function are poor in neurotmesis.<xref ref-type="bibr" rid="article-28765.r5">[5]</xref></p>
      </sec>
      <sec id="article-28765.s4" sec-type="Tissue Preparation">
        <title>Tissue Preparation</title>
        <p>Aldehyde is the preferred routine fixative for nervous tissue. Electron microscopy requires an aldehyde fixative with high purity.<xref ref-type="bibr" rid="article-28765.r6">[6]</xref>&#x000a0;After fixation, the sample gets embedded in either paraffin or epoxy. Paraffin allows for the study of the entire cross-sectional area of a nerve and is the preferred medium for light microscopy and larger nerve sections. Epoxy is preferable for smaller nerve branches and visualization with electron microscopy.<xref ref-type="bibr" rid="article-28765.r7">[7]</xref> Recent utilization of cryofixation, high pressure freezing and freeze substitution, is a beneficial supplement to aldehyde fixation in electron microscopy and may improve the preservation of structure detail and contrast.<xref ref-type="bibr" rid="article-28765.r8">[8]</xref></p>
      </sec>
      <sec id="article-28765.s5" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>Immunohistochemical stains are valuable tools to differentiate Schwann cells from other cell types. S-100 is a protein unique to neural crest-derived cells, so anti-S-100 antibodies can be used to stain for healthy Schwann cells or nervous tissue neoplasms, such as schwannomas.<xref ref-type="bibr" rid="article-28765.r9">[9]</xref> Myelin basic protein (MBP) neutralizes phospholipid charges on the inner surface of the membrane and is present in Schwann cells but not satellite cells, the other major PNS glial cell.&#x000a0;Anti-MBP can be used to differentiate Schwann cells or oligodendrocytes from other glial cells.<xref ref-type="bibr" rid="article-28765.r10">[10]</xref> P0, a peripheral nerve myelin protein, is a transmembrane adhesion protein that promotes the extracellular lamellar apposition that forms the intraperiod lines.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref>&#x000a0;Anti-P0 can be used to identify granular cell tumors, which derive from Schwann cells.<xref ref-type="bibr" rid="article-28765.r11">[11]</xref></p>
      </sec>
      <sec id="article-28765.s6" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>Under light microscopy, Schwann cell nuclei and myelin sheath are visible, as well as their basal laminae and associated axons.<xref ref-type="bibr" rid="article-28765.r12">[12]</xref> Both light and electron microscopy demonstrate myelin sheaths of various thicknesses according to neuregulin expression by the axon. More heavily myelinated axons may have more than 40 lamellae, as visualized by alternating intraperiod and dense lines. Intraperiod lines demonstrate the apposition of extracellular surfaces of compact lamellae of the Schwann cell plasma membrane. Dense lines demonstrate the close apposition of the cytoplasmic surfaces of the membrane in compact myelin.<xref ref-type="bibr" rid="article-28765.r1">[1]</xref></p>
      </sec>
      <sec id="article-28765.s7" sec-type="Microscopy, Electron&#x0000d;&#x0000a;">
        <title>Microscopy, Electron
</title>
        <p>Under transmission electron microscopy, the lamellar structure and Schwann cell cytoplasmic content can be visualized clearly, including mitochondria, microtubules, and microfilaments. Osmium tetroxide is used to stain the myelin, allowing the dark (osmiophilic) myelin of myelinating Schwann cells&#x000a0;to be clearly distinguished from the lighter membranes of the non-myelinating Schwann cells. Myelinating Schwann cells can be seen surrounding a single axon with a myelin sheath, though it may also have unmyelinated axons associated with its outer cytoplasm. Bundles of unmyelinated axons are visible, settled&#x000a0;into the cytoplasm of a non-myelinating Schwann cell. Endoneurium, the loose connective tissue sheaths that surround individual nerve fibers, can also be visualized.<xref ref-type="bibr" rid="article-28765.r12">[12]</xref></p>
      </sec>
      <sec id="article-28765.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The major diseases involving Schwann cells are demyelinating or neoplastic processes. Disorders that cause damage to the myelin sheath in the PNS, affecting the function of Schwann cells and axons, are called peripheral demyelinating diseases. Various insults, such as genetic mutations, infections, trauma, and autoimmune processes can trigger this demyelination and eventual neurodegeneration. Guillain-Barre Syndrome is a rare autoimmune peripheral demyelinating disease characterized by acute ascending flaccid paralysis, which can be life-threatening if the disease affects the muscles of respiration. It is often associated with a preceding infection of the gastrointestinal or respiratory tract, particularly <italic toggle="yes">C. jejuni </italic>and associated anti-GM1 and anti-GD1a antibodies. The association with infection and accumulation of anti-ganglioside antibodies suggests that ganglioside-like antigens found on <italic toggle="yes">C. jejuni </italic>lead to the production of antibodies that are cross-reactive with myelinating cells of the PNS. Guillain-Barre can also be caused by other pathogens, trauma, surgery, monoclonal antibody treatment, and rarely by vaccination. The patients usually present with proximal muscle weakness of lower extremity. The most common variant of Guillain-Barre is acute inflammatory demyelinating polyradiculopathy (AIDP), which presents histologically with segmental demyelination with lymphocytic and monocytic infiltration.<xref ref-type="bibr" rid="article-28765.r13">[13]</xref><xref ref-type="bibr" rid="article-28765.r14">[14]</xref></p>
        <p>Charcot-Marie-Tooth disease (CMT) is a rare hereditary peripheral demyelinating disorder, most commonly with autosomal dominant inheritance. Several subtypes affect different proteins and can affect both sensory and motor nerves, but all disrupt Schwann cell structure and function. PMP22 is the most commonly affected protein and causes CMT1A, leading to growth arrest in Schwann cells and abnormal Schwann cell number between nodes of Ranvier. CMT1 is characterized by segmental demyelination and remyelination, causing onion skin appearance on biopsy, and greatly reduced conduction velocity of nerves.<xref ref-type="bibr" rid="article-28765.r13">[13]</xref><xref ref-type="bibr" rid="article-28765.r15">[15]</xref>&#x000a0;</p>
        <p>Diabetes mellitus is associated with hyperglycemia, hyperlipidemia, hypertension, and impaired insulin signaling, which can damage microvasculature, leading to the common complication of diabetic peripheral neuropathy. Diabetic neuropathy is due to damage to Schwann cells and axons in both sensory and motor nerves. Schwann cells appear to be more susceptible to direct damage caused by hyperglycemia. In contrast, neurons are highly metabolically active, and function better in a hyperglycemic environment but are at greater risk of degeneration caused by hypoxia and loss of trophic support from Schwann cells. Hyperglycemia causes Schwann cell dysfunction, production of reactive oxygen species, initiation of the inflammatory cascade, disruptions in axon conduction, and impaired regeneration after nerve damage.<xref ref-type="bibr" rid="article-28765.r2">[2]</xref></p>
        <p>Schwannomas, neurofibromas, and malignant peripheral nerve sheath tumors (MPNSTs) are all neoplastic conditions that arise from Schwann cells. Schwannomas are typically solitary encapsulated lesions made exclusively of neoplastic Schwann cells. Schwannomas do not invade the associated nerve but may produce symptoms caused by mass effect. Neurofibromas and MPNSTs are made of multiple cell types, including Schwann cells, and commonly infiltrate the associated nerve. Neurofibromas commonly arise in patients with neurofibromatosis 1 (NF1), an autosomal dominant disorder caused by a mutation in the <italic toggle="yes">NF1</italic> tumor suppressor gene, which may present with dermal and/or plexiform neurofibromas. Dermal neurofibromas are hormone-sensitive tumors that begin to appear as NF1 patients enter puberty, and these tumors have little to no malignant potential. Plexiform neurofibromas are often congenital, not hormone-responsive, and can undergo malignant transformation to MPNSTs.<xref ref-type="bibr" rid="article-28765.r16">[16]</xref><xref ref-type="bibr" rid="article-28765.r17">[17]</xref></p>
      </sec>
      <sec id="article-28765.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Guillain-Barre manifests clinically with symmetric ascending paralysis and paresthesia, which may progress to dyspnea and choking over hours to days. Management is supportive and, with ventilatory support and monitoring for cardiac arrhythmias and other complications, the prognosis is good with patients typically recovering function within 12 months.<xref ref-type="bibr" rid="article-28765.r13">[13]</xref>&#x000a0;The earlier the clinician identifies and treats the condition, the better the prognosis.&#x000a0;In randomized controlled trials, there are two treatment options currently&#x000a0;considered the standard of care in Guillain-Barre syndrome (GBS). These include either intravenous immunoglobulin (IVIG) or plasma exchange. IVIG is thought to act by its immune-modulating action; however, the exact mechanism remains unclear. IVIG dosing is 2 grams/kilogram divided over 5 days.<xref ref-type="bibr" rid="article-28765.r18">[18]</xref> [Level I] Plasma exchange is thought to act by removing pathogenic antibodies, humoral mediators, and complement proteins involved in the pathogenesis of GBS. Similar to IVIG,&#x000a0;its&#x000a0;exact mechanism of action in the treatment of GBS remains unproven. The patient generally receives plasma exchange as a volume of an exchange over five sessions.</p>
        <p>Patients with CMT may present with distal muscle weakness, foot drop, depressed or absent deep tendon reflexes, atrophy of muscles of below the knee, and atrophy of the muscles of the thenar eminence. CMT does not reduce the lifespan, and management is supportive.<xref ref-type="bibr" rid="article-28765.r13">[13]</xref><xref ref-type="bibr" rid="article-28765.r15">[15]</xref></p>
        <p>Diabetic neuropathy classically arises in patients with long-standing diabetes as a sensory neuropathy with loss of temperature, vibration, touch, and pain sensation. Patients may also have accompanying neuropathic pain. Nerve damage progresses from small sensory fibers to large sensory fibers, to large motor fibers, causing weakness, loss of function, and paralysis. Nerve damage also is more pronounced in distal extremities, a characteristic &#x0201c;stocking-glove&#x0201d; pattern. Treatment of diabetic neuropathy is limited to symptomatic treatment of neuropathic pain and maintenance of euglycemia to prevent the development of diabetic neuropathy or slow its progression.<xref ref-type="bibr" rid="article-28765.r2">[2]</xref></p>
        <p>Schwann cell neoplasms can be identified by immunohistochemistry for Schwann cell markers such as S-100. Management varies from monitoring and supportive care for asymptomatic dermal neurofibromas to surgery, chemotherapy, and radiation for metastatic MPNSTs.<xref ref-type="bibr" rid="article-28765.r16">[16]</xref><xref ref-type="bibr" rid="article-28765.r17">[17]</xref><xref ref-type="bibr" rid="article-28765.r19">[19]</xref><xref ref-type="bibr" rid="article-28765.r20">[20]</xref></p>
      </sec>
      <sec id="article-28765.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28765&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28765">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28765/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28765">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28765.s11">
        <fig id="article-28765.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Schwann cell Image courtesy Dr Chaigasame</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Schwann__cell" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28765.s12">
        <title>References</title>
        <ref id="article-28765.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salzer</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Zalc</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Myelination.</article-title>
            <source>Curr Biol</source>
            <year>2016</year>
            <month>Oct</month>
            <day>24</day>
            <volume>26</volume>
            <issue>20</issue>
            <fpage>R971</fpage>
            <page-range>R971-R975</page-range>
            <pub-id pub-id-type="pmid">27780071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>V&#x000e6;gter</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>&#x000d8;stergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Calcutt</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Schwann cell interactions with axons and microvessels in diabetic neuropathy.</article-title>
            <source>Nat Rev Neurol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>135</fpage>
            <page-range>135-147</page-range>
            <pub-id pub-id-type="pmid">28134254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salzer</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Schwann cell myelination.</article-title>
            <source>Cold Spring Harb Perspect Biol</source>
            <year>2015</year>
            <month>Jun</month>
            <day>08</day>
            <volume>7</volume>
            <issue>8</issue>
            <fpage>a020529</fpage>
            <pub-id pub-id-type="pmid">26054742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feltri</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Poitelon</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Previtali</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>How Schwann Cells Sort Axons: New Concepts.</article-title>
            <source>Neuroscientist</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-65</page-range>
            <pub-id pub-id-type="pmid">25686621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jessen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Mirsky</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Schwann Cells: Development and Role in Nerve Repair.</article-title>
            <source>Cold Spring Harb Perspect Biol</source>
            <year>2015</year>
            <month>May</month>
            <day>08</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>a020487</fpage>
            <pub-id pub-id-type="pmid">25957303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fix</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Garman</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Practical aspects of neuropathology: a technical guide for working with the nervous system.</article-title>
            <source>Toxicol Pathol</source>
            <year>2000</year>
            <season>Jan-Feb</season>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>122</fpage>
            <page-range>122-31</page-range>
            <pub-id pub-id-type="pmid">10668998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miko</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Gschmeissner</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Histological methods for assessing myelin sheaths and axons in human nerve trunks.</article-title>
            <source>Biotech Histochem</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>68</fpage>
            <page-range>68-77</page-range>
            <pub-id pub-id-type="pmid">8204769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000f6;bius</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nave</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Electron microscopy of myelin: Structure preservation by high-pressure freezing.</article-title>
            <source>Brain Res</source>
            <year>2016</year>
            <month>Jun</month>
            <day>15</day>
            <volume>1641</volume>
            <issue>Pt A</issue>
            <fpage>92</fpage>
            <page-range>92-100</page-range>
            <pub-id pub-id-type="pmid">26920467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakazato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ishizeki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical localization of S-100 protein in granular cell myoblastoma.</article-title>
            <source>Cancer</source>
            <year>1982</year>
            <month>Apr</month>
            <day>15</day>
            <volume>49</volume>
            <issue>8</issue>
            <fpage>1624</fpage>
            <page-range>1624-8</page-range>
            <pub-id pub-id-type="pmid">6175391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dupin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baroffio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dulac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cameron-Curry</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Douarin</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Schwann-cell differentiation in clonal cultures of the neural crest, as evidenced by the anti-Schwann cell myelin protein monoclonal antibody.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>1119</fpage>
            <page-range>1119-23</page-range>
            <pub-id pub-id-type="pmid">1967835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors.</article-title>
            <source>Am J Pathol</source>
            <year>1983</year>
            <month>Aug</month>
            <volume>112</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-46</page-range>
            <pub-id pub-id-type="pmid">6192721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sha</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The use of fiber-reinforced scaffolds cocultured with Schwann cells and vascular endothelial cells to repair rabbit sciatic nerve defect with vascularization.</article-title>
            <source>Biomed Res Int</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>362918</fpage>
            <pub-id pub-id-type="pmid">24490158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamil</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yazid</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Idrus</surname>
                <given-names>RBH</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Peripheral Demyelinating Diseases: From Biology to Translational Medicine.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>87</fpage>
            <pub-id pub-id-type="pmid">30941082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steck</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Czaplinski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renaud</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.</article-title>
            <source>Neurotherapeutics</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>528</fpage>
            <page-range>528-34</page-range>
            <pub-id pub-id-type="pmid">19019303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Font&#x000e9;s</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Charcot Marie Tooth Disease. A Single Disorder?</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Nov</month>
            <day>29</day>
            <volume>19</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">30501086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carroll</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.</article-title>
            <source>Acta Neuropathol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>321</fpage>
            <page-range>321-48</page-range>
            <pub-id pub-id-type="pmid">22160322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Charnay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Parada</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Neurofibromas in NF1: Schwann cell origin and role of tumor environment.</article-title>
            <source>Science</source>
            <year>2002</year>
            <month>May</month>
            <day>03</day>
            <volume>296</volume>
            <issue>5569</issue>
            <fpage>920</fpage>
            <page-range>920-2</page-range>
            <pub-id pub-id-type="pmid">11988578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ar&#x000e1;nyi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kov&#x000e1;cs</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sipos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bereczki</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings.</article-title>
            <source>Eur J Neurol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-20, e1-3</page-range>
            <pub-id pub-id-type="pmid">21631649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staedtke</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Blakeley</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.</article-title>
            <source>Neurotherapeutics</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>298</fpage>
            <page-range>298-306</page-range>
            <pub-id pub-id-type="pmid">28349408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28765.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutmann</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ferner</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Listernick</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Korf</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Wolters</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Neurofibromatosis type 1.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2017</year>
            <month>Feb</month>
            <day>23</day>
            <volume>3</volume>
            <fpage>17004</fpage>
            <pub-id pub-id-type="pmid">28230061</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
